Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as reduction in tumor weight at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days relative to control
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as change in ratio of CD8+/CD3+ cells at 40 mg/kg, ip administered every other day from day 6 post implantation by flow cytometry
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as change in ratio of CD3+/CD45+ cells at 40 mg/kg, ip administered every other day from day 6 post implantation by flow cytometry
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as infiltration of CD8 cells at 40 mg/kg, ip administered every other day from day 6 post implantation by flow cytometry (Rvb = 26.9 %)
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as infiltration of CD3 cells at 40 mg/kg, ip administered every other day from day 6 post implantation by flow cytometry (Rvb = 1.45 %)
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as infiltration of CD45 cells at 40 mg/kg, ip administered every other day from day 6 post implantation by flow cytometry (Rvb = 1.81 %)
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse coadministered with anti-CD8 antibody assessed as suppression of tumor growth at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days
Induction of immune response mediated antitumor activity in mouse B16F10 cells xenografted in C57/BL mouse assessed as reduction in tumor volume at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days relative to control
Toxicity in mouse B16F10 cells xenografted C57/BL mouse assessed as change in body weight at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days
Induction of immune response mediated antitumor activity in mouse MC38 cells xenografted in C57/BL mouse assessed as tumor growth inhibition at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days
Toxicity in mouse MC38 cells xenografted C57/BL mouse assessed as change in body weight at 40 mg/kg, ip administered every other day from day 6 post implantation measured every 2 days
Immunomodulatory activity in mouse MC38 cells xenografted in C57/BL mouse assessed as increase in infiltration of CD3-positive T cells at 40 mg/kg, ip administered every other day from day 6 post implantation by DAPI staining based immunofluorescence microscopy
Immunomodulatory activity in mouse MC38 cells xenografted in C57/BL mouse assessed as increase in perforin at 40 mg/kg, ip administered every other day from day 6 post implantation by hematoxylin staining based immunohistochemical analysis
Immunomodulatory activity in mouse MC38 cells xenografted in C57/BL mouse assessed as increase in granzyme B at 40 mg/kg, ip administered every other day from day 6 post implantation by hematoxylin staining based immunohistochemical analysis
Immunomodulatory activity in mouse MC38 cells xenografted in C57/BL mouse assessed as increase in infiltration of CD8-positive T cells at 40 mg/kg, ip administered every other day from day 6 post implantation by DAPI staining based immunofluorescence microscopy
Immunomodulatory activity in human MDA-MB-231 cells cocultured with human PBMC assessed as induction of PBMC recruitment to MDA-MB-231 cells by measuring increase in activated caspase-3 at 20 uM incubated for 24 hrs by GrennNuc caspase-3 substrate based assay
Induction of apoptosis in human MDA-MB-231 cells assessed as activated caspase-3 at 20 uM incubated for 24 hrs by GrennNuc caspase-3 substrate based assay
Immunomodulatory activity in human MDA-MB-231 cocultured with PMBC assessed as induction of PBMC recruitment to MDA-MB-231 cells by measuring increase in cell cluster at 20 uM incubated for 12 to 48 hrs by EVOS FL digital microscopic analysis
Immunomodulatory activity in human CFDA SE-labelled MDA-MB-231 cells cocultured with PMBC assessed as induction of PBMC recruitment to MDA-MB-231 cells by measuring early apoptotic cells at 20 uM incubated for 48 hrs by propidium iodide staining based flow cytometry analysis (Rvb = 0 %)